Garrison Financial Corp bought a new position in shares of Waters Co. (NYSE:WAT) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 1,744 shares of the medical instruments supplier’s stock, valued at approximately $276,000.
A number of other large investors have also modified their holdings of the business. Bank of New York Mellon Corp lifted its holdings in shares of Waters by 156.1% in the second quarter. Bank of New York Mellon Corp now owns 4,358,976 shares of the medical instruments supplier’s stock worth $843,852,000 after buying an additional 2,657,055 shares in the last quarter. Morgan Stanley lifted its holdings in shares of Waters by 188.1% in the third quarter. Morgan Stanley now owns 527,562 shares of the medical instruments supplier’s stock worth $102,707,000 after buying an additional 344,432 shares in the last quarter. Select Equity Group L.P. lifted its holdings in shares of Waters by 81.8% in the third quarter. Select Equity Group L.P. now owns 406,245 shares of the medical instruments supplier’s stock worth $79,088,000 after buying an additional 182,841 shares in the last quarter. Nordea Investment Management AB lifted its holdings in shares of Waters by 3,557.4% in the third quarter. Nordea Investment Management AB now owns 154,597 shares of the medical instruments supplier’s stock worth $30,098,000 after buying an additional 150,370 shares in the last quarter. Finally, Man Group plc raised its stake in Waters by 61.4% in the third quarter. Man Group plc now owns 313,891 shares of the medical instruments supplier’s stock valued at $61,109,000 after purchasing an additional 119,451 shares in the last quarter. Hedge funds and other institutional investors own 96.14% of the company’s stock.
A number of equities research analysts recently weighed in on the stock. Zacks Investment Research raised shares of Waters from a “hold” rating to a “buy” rating and set a $256.00 target price on the stock in a research note on Wednesday, January 30th. Goldman Sachs Group downgraded shares of Waters from a “neutral” rating to a “sell” rating and lowered their target price for the company from $185.00 to $180.00 in a research note on Friday, November 30th. TheStreet downgraded shares of Waters from a “b” rating to a “c+” rating in a research note on Thursday, December 20th. BTIG Research raised their target price on shares of Waters to $260.00 and gave the company a “buy” rating in a research note on Thursday, January 24th. Finally, UBS Group lowered their target price on shares of Waters from $210.00 to $200.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 24th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $208.99.
Shares of WAT stock traded up $1.41 during trading hours on Tuesday, hitting $233.76. 71,376 shares of the company’s stock were exchanged, compared to its average volume of 719,214. The company has a market capitalization of $17.50 billion, a PE ratio of 28.20, a price-to-earnings-growth ratio of 2.28 and a beta of 1.17. Waters Co. has a 12-month low of $167.93 and a 12-month high of $233.48. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.01 and a current ratio of 2.26.
Waters (NYSE:WAT) last posted its quarterly earnings results on Wednesday, January 23rd. The medical instruments supplier reported $2.87 EPS for the quarter, topping the consensus estimate of $2.64 by $0.23. The firm had revenue of $715.00 million for the quarter, compared to the consensus estimate of $702.74 million. Waters had a net margin of 24.54% and a return on equity of 34.18%. The business’s revenue was up 4.0% compared to the same quarter last year. During the same period last year, the firm posted $2.51 earnings per share. On average, research analysts predict that Waters Co. will post 9.35 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This article was reported by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another publication, it was stolen and republished in violation of US and international copyright legislation. The legal version of this article can be viewed at https://www.tickerreport.com/banking-finance/4146232/1744-shares-in-waters-co-wat-purchased-by-garrison-financial-corp.html.
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Article: Stochastic Momentum Index (SMI)
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.